Navigation Links
Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement
Date:3/2/2011

BOSTON, March 2, 2011 /PRNewswire/ -- Joslin Diabetes Center has launched a groundbreaking initiative for primary care physicians to improve diabetes care. Joslin, with technology from Forward Health Group, Inc., is providing qualifying primary care practices in the United States with the critical capability to extract usefulness out of existing clinical data at the individual patient level, and to combine this information with practice improvement support and education. The initiative is supported via independent continuing medical education (CME) grant funding provided by GlaxoSmithKline and Merck & Co.

"To move the needle toward real improvement in diabetes, we need to know where the gaps are in order to provide targeted education and resources to improve," said Richard Beaser, M.D., Medical Executive Director for Joslin Professional Education. "This initiative does exactly that."

Using clinical informatics tools provided by Forward Health Group, Joslin is providing enhanced electronic clinical data capture and outcomes data visualization capabilities to qualifying practitioners.  Each practitioner is then directed to a suite of Joslin education, tools and resources targeted to individual gaps to support improvement over time well beyond the scope of the performance improvement (PI) CME activity alone.

"This initiative truly has the potential to be transformational," said Michael Barbouche, Founder/CEO of Forward Health Group. "The world's leading provider of clinical care, research and education in diabetes can now provide total population data for the busy primary care doctor.  Participating physicians can view their entire panel of patients, identify gaps in execution and delivery of care, and rely on Joslin education resources to improve. It's a great opportunity for practices to improve where they most need it and meet important quality benchmarks and certain CME and potentially Maintenance of Certification (MOC) requirements without having to invest many hours in manually abstracting charts."

In addition to data support, participating practices will have access to proven education and point of care tools and resources and other dedicated Joslin staff support.  Joslin is actively recruiting practices. Interested parties should contact Karen Kuc at 617-226-5933 or karen.kuc@joslin.harvard.edu.

About Joslin Diabetes Center and Joslin Professional EducationJoslin Diabetes Center is the world's preeminent diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent, nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, visit www.joslin.org.

Joslin Diabetes Center, accredited since 1995, was most recently awarded Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) in 2006.  Joslin's innovative performance improvement focused CME program for physicians and other health professionals advance the highest standards of care. The program includes live symposia and courses, Audio CD's, mobile applications, Web-based educational activities, and Performance Improvement CME Pathways. For more information about Joslin Professional Education and Joslin PI CME pathways visit www.jpec.joslin.org.

About Forward Health GroupForward Health Group is a leading-edge clinical informatics company, transforming fragmented clinical and administrative healthcare data stored in disparate systems, into actionable information that can be used to drive population health improvement. For more information, visit www.forwardhealthgroup.com.Contacts:Eric BenderSenior Communications Specialist, Joslin Diabetes Center617-309-2418 or eric.bender@joslin.harvard.edu .Barry WightmanVice President, Marketing, Forward Health Group, Inc.414 418 5654 or bmw@forwardhealthgroup.com
'/>"/>

SOURCE Forward Health Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
2. Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
3. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
4. Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
5. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
6. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
7. Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico
8. Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award
9. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
10. Use of Non-Traditional Providers in the Phoenix Market Will Improve Diabetes Prescription Drug Adherence
11. Reportlinker Adds Diabetes Market to 2016 - Biguanides and Insulin Analogs will be the Largest Selling Anti-Diabetic Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):